Showing results (21-30 of 39) with videos related to
Sort By:
Pageof 4
Therapeutic Advances in Neurological Disorders|March 18, 2024
Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populationsAlexander Stahmann, Elaine Craig, David Ellenberger, et al.European Journal of Neurology|July 9, 2021
Prevalence of pediatric multiple sclerosis in Germany: A nationwide population-based analysisNiklas Frahm, Melanie Peters, Jörg Bätzing, et al.Pharmaceutics|March 26, 2022
Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without PolypharmacyPaula Bachmann, Niklas Frahm, Jane Louisa Debus, et al.Neurology and Therapy|July 3, 2026
Polypharmacy, Potential Drug-Drug Interactions and Medication Non-Adherence in Patients with Multiple Sclerosis: A Longitudinal StudyAvinash M Suntah, Michael Hecker, Bassel Barhoum, et al.Scientific Reports|May 28, 2024
Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosisKatja Burian, Felicita Heidler, Niklas Frahm, et al.Therapeutic Advances in Neurological Disorders|October 16, 2024
Personality traits in patients with multiple sclerosis: their association with nicotine dependence and polypharmacyJanina Meißner, Niklas Frahm, Michael Hecker, et al.Therapeutic Advances in Drug Safety|April 3, 2023
Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancyMarie-Celine Haker, Niklas Frahm, Michael Hecker, et al.Journal of Clinical Medicine|April 26, 2025
Trauma Burden Affected People with Multiple Sclerosis During SARS-CoV-2 PandemicFelicita Heidler, Michael Hecker, Niklas Frahm, et al.Journal of Clinical Medicine|August 26, 2023
Depression and Anxiety in Association with Polypharmacy in Patients with Multiple SclerosisJulia Baldt, Niklas Frahm, Michael Hecker, et al.Frontiers in Pharmacology|August 29, 2022
Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databasesMichael Hecker, Niklas Frahm, Paula Bachmann, et al.Pageof 4